Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic Products, and Viral Diagnostic Kits segments. The company’s products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system. It also offers cosmetic products, such as Odd Beroni AGG skin rejuvenation and wrinkle care facial masks. In addition, the company provides SARS-CoV-2 antibody and antigen detection kits, as well as CII-ArboViroPlex rRT-PCR assay, a diagnostic kit used to detect viruses such as Zika, Dengue, Chikungunya, and West Nile. Further, it engages in the research and development of anti-cancer drugs and cell therapies; provision of e-commerce platform for pharmaceutical and healthcare products; and detection and diagnosis of infectious diseases. The company was founded in 2014 and is headquartered in Sydney, Australia.